Abstract 15701: Histone Deacetylase 6Inhibition Demonstrates Comparable Efficacy as Empagliflozin in a Mouse Model of Heart Failure With Preserved Ejection Fraction
Jin Yang(Rapt Therapeutics (United States)), Tim Hoey, Xiaomei Song, Farshad Farshidfar(Institute for Stem Cell Biology and Regenerative Medicine), Gretchen Argast(Rapt Therapeutics (United States)), Iris Wu(University of Michigan), Jay Vora, Matt Holdren, Amara Greer-Short(Unknown), S. M. Vaziri, Aliya Zeng
Cited by 1
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
|British Journal of Cancer|2016|136
Epidermal Growth Factor Receptor Transactivation Mediates Tumor Necrosis Factor-induced Hepatocyte Replication
|Journal of Biological Chemistry|2004|104
Revealing the Concealed Nature of Long-QT Type 3 Syndrome
|Circulation Arrhythmia and Electrophysiology|2017|59